phmacao casino

phmacao casino COLUMBUS, Ohio — Despite everyone counting them out, including the oddsmakers installing them as three-touchdown underdogs, Michigan players said early in the week their intention was to play loose and have fun. The Wolverines entered the 120th meeting against arch-rival Ohio State on the heels of reaching six wins and bowl eligibility, while the Buckeyes (10-1, 7-1 Big Ten) were ranked No. 2 and on a roll. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.Iceland votes for a new parliament after political disagreements force an early election

How Gen X and millennials are changing the face of the traditional family office as they inherit over $80 trillion

WILLIMANTIC — “Eurydice,” which reimagines the Orpheus myth, concludes Eastern’s fall theatre season. The Communications, Film and Theater Department, along with the Drama Society at Eastern Connecticut State University, is excited to present “Eurydice,” a play written by Sarah Ruhl and directed by Tim Golebiewski, a lighting technology specialist and lecturer at Eastern. This contemporary reimagining of the Greek myth of Orpheus will serve as the grand finale of Eastern’s mainstage season for fall 2024. Read the full story in the print or e-edition of the Chronicle.

Why are so many royals podcasting? And is anyone listening?Elon Musk, the world's richest person and one of Donald Trump's closest allies, met with US lawmakers Thursday on his plans for overseeing radical government spending cuts under the incoming administration. President-elect Trump rewarded the Tesla, X and SpaceX chief for his support during the White House campaign by naming him head of the newly created Department of Government Efficiency, along with another wealthy ally, Vivek Ramaswamy. Although the office, dubbed DOGE, has a purely advisory role, Musk's star power and intense influence in Trump's inner circle bring political clout. As Musk and Ramaswamy strode into the Capitol for meetings with lawmakers, Republican Speaker Mike Johnson touted "a new day in America." "There's an enormous amount of waste, fraud and abuse," he told reporters. "Government is too big, it does too many things, and it does almost nothing well." Musk and Ramaswamy have said they can identify billions of dollars of cuts in spending, sparking questions about whether Republicans will even try to slash politically popular social security programs. Writing in the Wall Street Journal last month, the two businessmen laid out plans for the White House to cut staff, trim government programs and reduce federal regulations, even if it means bypassing Congress, which holds budgetary power. "The entrenched and ever-growing bureaucracy represents an existential threat to our republic, and politicians have abetted it for too long," Musk and Ramaswamy wrote. "We're doing things differently. We are entrepreneurs, not politicians. During Trump's election campaign, Musk vowed to reduce federal spending by $2 trillion. This would represent cutting total US spending by a third, almost certainly meaning devastation of social support programs -- something that has never garnered strong political backing. Musk's emphasis on firing large numbers of government employees, however, echoes Republican talking points about the need to take on an overbearing state and may garner more support. Musk says he is seeking "mass head-count reductions across the federal bureaucracy." Musk suggested banning government employees from working at home as an opening tactic. "Requiring federal employees to come to the office five days a week would result in a wave of voluntary terminations that we welcome." Cuts will also target subsidies to public broadcasters and groups such as Planned Parenthood, which campaigns for abortion access and offers an array of reproductive health services. But DOGE is unlikely, at least initially, to go after welfare programs such as Social Security or health insurance for the poor and seniors, Ramaswamy said in an interview with Axios on Wednesday. Such cuts should be "a policy decision that belongs to the voters" and their representatives in Congress, Ramaswamy said. A reduction in military spending, which climbed to $820 billion in 2023, is also unlikely to be on the table. Musk's new role raises the question of potential conflicts of interest, since he could be issuing policy recommendations that impact directly on his own business empire. Underlining the close connection to DOGE, Musk's favorite cryptocurrency is called Dogecoin. rle/ev/md/sms/md

Musk heads to US Congress to discuss slashing government costsHigh-Yield Savings Platforms Using Blockchain

Pitt QB Eli Holstein carted off with leg injury

The New York Knicks haven’t received consistent production from the bench, but a particular signing could help the organization fix their second unit woes. In a wise present and future-driven move , the Knicks could bring back a veteran long-range sniper to help give them a spark off the bench. “Looking ahead, sharpshooter Landry Shamet is expected to be re-signed by the Knicks when he’s healthy, with the hope that stretch forward Matt Ryan will then clear waivers and re-sign on a two-way contract,” HoopsHype’s Michael Scotto wrote Monday. Shamet, a 2018 first-round pick, suited up for the Washington Wizards during the 2023-24 season. The Wichita State product averaged 7.1 points on 33.8% shooting from beyond the arc in 46 contests, which didn’t earn him another contract with the organization. Shamet found a new NBA home in October, signing a non-guaranteed training camp deal with the Knicks. The 38.4% career three-point shooter struggled to find his touch from deep during the preseason, but he netted 43 total points in four contests. Unfortunately, Shamet dislocated his shoulder during the Knicks’ final preseason game against the Charlotte Hornets, which compelled the franchise to waive him before New York’s season opener. If Shamet wishes to rejoin the Knicks this season, he must improve his health and return to his scorching ways from three-point land. With New York looking to exit laughingstock territory regarding their bench scoring, they may give Shamet another opportunity to prove he belongs in the big leagues. More NBA: Lakers could hit jackpot by acquiring $242 million trio in multi-team tradeThe year 2024 on many accounts is another legacy year, carrying forward the aatmanirbhartha push in the Indian defence sector, a resolve to reduce dependence on imports of military products that got strengthened due to the global conflicts beginning with Russia-Ukraine war. The defence production continued to soar, exports to 100 countries is on the uptick and so does the attempts to curtail capability deficiency. But in many ways 2024 turned out to be a year for recalibration of defence ties with key nations for strategic autonomy. The breakthrough in the India-China border talks announced on October 21 ended the four-year long standoff that began due to the bloody Galwan Attack.The diplomatic event, still unfolding, stood out as the high-point for India’s multinational foreign policy, lowering a bit animosity between the Asian giants. whose relationship at one point of time was defined through the slogan of “Hindi-Chini bhai bhai”. Now the patrolling has resumed on mutually agreed grids following military disengagement in friction points of Depsang and Demchok in Easter Ladakh to the pre 2020 April positions. But, other contentious issues like addressing buffer zones which are no go areas for both the troops in Northern borders, and continued hostilities in eastern sector of Arunachal Pradesh, which also saw skirmish among the troops of Indian Army and Chinese PLA on December 9, 2022, remain unresolved. Though Indian defence forces are not willing to lower their guard at the LAC given that the trust deficit remains against the principal adversary, the meeting between Chinese Foreign Minister Wang Yi and India’s National Security Adviser Ajit Doval in Beijing on December 18 has set encouraging agenda for building further consensus on border issues. Doval and Wang “reaffirmed their commitment to continue seeking a fair, reasonable, and mutually acceptable package solution to the boundary issue”. Both agreed to take “positive measures to promote this process”, as per a statement put out after the special representatives meeting in Beijing. However, sources in the Defence Ministry stated that long lasting solution for border dispute is still far away for a variety of reasons, primary among them is that China’s territorial ambitions including in Indo Pacific region is still intact and that they would like to keep such irritants for negotiations in future. Notwithstanding that, government officials said that the thaw in the relationship will help the MoD to go ahead and formalise the jointness of the tri-services without any immediate fear of lurking danger at the LAC and Line of Control with Pakistan. An announcement for theaterisation of forces is expected to happen next year, may be a bit early. It will also encourage the MoD to pursue with same vigour modernisation of the armed forces to equip and train soldiers for the tech-driven future warfare. Defence Minister Rajnath Singh’s visit to Moscow early this month too signifies an important development in the country’s military diplomacy. It exhibited that India is willing to absorb diplomatic compulsions from Washington, which government officials here believe may be not that intense with Donald Trumph’s return to White House, in its renewed defence engagement with Russia. This was quite apparent from Singh’s comment post 21st meeting of India-Russia Inter-Governmental Commission with his Russian counterpart, Andrey Belousov, on December 10. “Despite geopolitical challenges and great pressure on India, both in public and in private, India has made a conscious decision that the country will not only continue close contacts with Russia but will also deepen and expand our interaction. We will always be with our Russian colleagues,” Singh was quoted as having said by Russian Defence Ministry. It was primarily to restore supply chain disruptions, caused since the Russia-Ukraine conflict, impacting mobility of military products, expedite delays in acquisition of remaining two units of S-400 surface-to-air missile systems and its spares and Kamov helicopters, and explore more Transfer of Technology (TOT) for maintenance of Su-30MKI—frontline fighters of the Indian Air Force. MoD sources said Singh’s visit gained currency owing to India’s hunt for a foreign original equipment manufacturer (OEM) to locally develop a new engine, with 110 kN Class thrust, for the Advanced Medium Combat Aircraft (AMCA). India does not want to be dependent on the US for the aero engines. In June GE signed an MoU with the HAL for co-development of GE-414 engines which would produce 98 kN thrust to power Tejas LCA Mk-2 fighters. It’s earlier version, GE-404 engines, producing 84 kN thrust, will fly LCA MK-1A. The GE-404 engines supply, however, has been delayed affecting IAF’s induction plans to augment its depleting fighter jets fleet strength. Russia, on its part, will want to retrieve its share in global defence market which it lost due to sanctions after getting into war with Ukraine. According to Stockholm International Peace Research Institute (SIPRI) report of 2024, Russia’s export of defence products to India for the first time came down below half of its imports. It accounts for India’s 36 percent of arms imports. India’s military inventory has about 60 percent Russian origin products. The United States and France in Europe exploited this opportunity to fill in the void created by Russia in arms trade with India. According to a recent US Congress report, “The US government is actively encouraging India to reduce its dependence on Russian origin defence articles.” Alternatively, India’s defence exports to the US equally has grown to account for over 50 percent of the total exports, exceeding $2.8 billion during the last 5 years. India is also putting its ‘Look East’ act together to restore defence engagement with neighbours like Sri Laka, and Maldives though nose diving of relations with Bangladesh is a big worry. India’s rethinking on military diplomacy should also show up in the ability to successfully push arms sale in favourable catchment areas of Africa and South America. For that the government needs to bring another set of defence reforms to streamline policy on acquisitions, given that tendering process is still complicated and lengthy, and to facilitate exports. A company which got a contract for selling military hardware abroad about four months ago is still struggling to get export licence. A Defence Export Promotion Council, however, is in the process of being made to overcome such hurdles. SIDM president and industry veteran Rajinder Singh Bhatia, however, said that 2024 despite under the shadows of geo-political uncertainties, beamed reflections of India emerging as a land of opportunities especially in the defence sector. “Realisation of the need for self reliance and indigenisation in the domain of defence & security requirements, led to numerous policy reviews for ease of doing business and further integrating user/ armed forces , MoD and defence industry ; wherein SIDM played a pivotal role.” Comments

LOS ANGELES — The programs came calling, last winter, and Kyron Hudson deflected them all to his father. Between USC wide receiver Hudson and Oregon defensive tackle Keyon Ware-Hudson, father Chance reflected, he had about 12 teams reach out about the possibility of his sons entering the transfer portal. A few, Chance told the Southern California News Group back in the fall, were interested in package deals. And father Chance listened, because the money was hard to turn down. But Hudson, even through three years of inconsistent snaps and infrequent opportunity, didn’t want to leave USC. “His answer? From him?” Chance said in the fall, asked if Hudson thought about transferring. “Absolutely not. There was zero.” A breakout season and a reel of highlight catches later, though, and receiver Hudson has officially entered the portal following his redshirt junior season at USC, announcing his departure in a lengthy statement on X (formerly Twitter) . “I step forward,” Hudson wrote, “with gratitude for my time at USC and anticipation for what lies ahead.” In a room full of talented sophomores jockeying for snaps, the former Mater Dei High standout emerged as the most consistent veteran presence at receiver for USC in 2024, hauling in a career-best 38 catches for 462 yards in 12 games. His handful of one-handed grabs became a signature, a career-best 83-yard game against LSU and a couple of improbable catches helping USC earn an impressive Week 1 win . Even as game-to-game opportunities in Coach Lincoln Riley’s passing attack wavered, Hudson was a constant on the outside, racking up the most snaps of any Trojans receiver in 2024. Amid a late-season flu that swept through USC’s locker room down the stretch, Hudson had to receive an IV for fluids during the week of the Nebraska game, according to a source familiar with the situation. That Saturday, he still caught three passes for 35 yards and a touchdown. “I mean, he’s one of those guys – you just kind of, you can’t have enough of ’em in your program, that they just stay the course, they just keep getting better,” Riley said, earlier in the season, of Hudson. “There’s not, maybe always these massive jumps. But they’re always there. He always practices, he never misses anything, he never misses a rep.” That consistency, in turn, will be missed dearly in USC’s receivers room in 2024, with veteran leaders Hudson and Kyle Ford (out of eligibility) now moving on.ANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-appoints-gerardo-hernandez-as-chief-financial-officer-and-provides-updated-2024-financial-outlook-302320060.html SOURCE TransMedics Group, Inc.

White House press secretary Karine Jean-Pierre claimed on Dec. 2 that President Biden pardoned his son Hunter Biden of tax and gun crimes because “war politics” prompted Hunter’s prosecution — while insisting the Justice Department is not broadly politically biased, as President-elect Donald Trump claims. NY Post reporter Josh Christenson shares this story.